Compare AMAR REMEDIES with RELAXO FOOTWEARS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs RELAXO FOOTWEARS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES RELAXO FOOTWEARS AMAR REMEDIES/
RELAXO FOOTWEARS
 
P/E (TTM) x -0.5 100.1 - View Chart
P/BV x 0.1 18.6 0.3% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 AMAR REMEDIES   RELAXO FOOTWEARS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
RELAXO FOOTWEARS
Mar-19
AMAR REMEDIES/
RELAXO FOOTWEARS
5-Yr Chart
Click to enlarge
High Rs164874 18.8%   
Low Rs86635 13.5%   
Sales per share (Unadj.) Rs261.6184.8 141.6%  
Earnings per share (Unadj.) Rs17.414.1 123.0%  
Cash flow per share (Unadj.) Rs22.319.2 116.2%  
Dividends per share (Unadj.) Rs01.80 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs100.789.1 113.1%  
Shares outstanding (eoy) m26.16124.05 21.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.54.1 11.7%   
Avg P/E ratio x7.253.3 13.5%  
P/CF ratio (eoy) x5.639.4 14.3%  
Price / Book Value ratio x1.28.5 14.7%  
Dividend payout %012.7 0.0%   
Avg Mkt Cap Rs m3,27093,596 3.5%   
No. of employees `000NA6.3 0.0%   
Total wages/salary Rs m1632,587 6.3%   
Avg. sales/employee Rs ThNM3,665.0-  
Avg. wages/employee Rs ThNM413.6-  
Avg. net profit/employee Rs ThNM280.5-  
INCOME DATA
Net Sales Rs m6,84422,921 29.9%  
Other income Rs m21130 16.2%   
Total revenues Rs m6,86523,051 29.8%   
Gross profit Rs m1,1313,243 34.9%  
Depreciation Rs m128624 20.5%   
Interest Rs m39869 576.8%   
Profit before tax Rs m6262,680 23.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121925 13.1%   
Profit after tax Rs m4551,754 25.9%  
Gross profit margin %16.514.1 116.8%  
Effective tax rate %19.334.5 56.0%   
Net profit margin %6.67.7 86.9%  
BALANCE SHEET DATA
Current assets Rs m4,9047,201 68.1%   
Current liabilities Rs m3,5814,560 78.5%   
Net working cap to sales %19.311.5 167.8%  
Current ratio x1.41.6 86.7%  
Inventory Days Days12464 194.3%  
Debtors Days Days10031 319.9%  
Net fixed assets Rs m1,6898,595 19.7%   
Share capital Rs m262124 211.3%   
"Free" reserves Rs m2,35810,927 21.6%   
Net worth Rs m2,63511,051 23.8%   
Long term debt Rs m5070-   
Total assets Rs m6,86216,046 42.8%  
Interest coverage x2.639.8 6.5%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.4 69.8%   
Return on assets %12.411.4 109.4%  
Return on equity %17.315.9 108.8%  
Return on capital %31.024.9 124.6%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273872 31.3%   
Fx outflow Rs m24,466 0.0%   
Net fx Rs m271-3,594 -7.5%   
CASH FLOW
From Operations Rs m-3131,235 -25.3%  
From Investments Rs m-489-569 85.8%  
From Financial Activity Rs m769-682 -112.6%  
Net Cashflow Rs m-33-12 262.1%  

Share Holding

Indian Promoters % 25.5 75.0 34.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.0 -  
FIIs % 0.0 1.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 23.9 273.2%  
Shareholders   13,061 3,357 389.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   EMAMI  LINC PEN & PLASTICS  MARICO  P&G HYGIENE  GODREJ CONSUMER  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

5 Reasons Why Sensex and Nifty Plunged 2% Today(Closing)

Indian share markets witnessed heavy selling pressure today despite the US administration saying it would bring a stimulus package even without the opposition's support.

Related Views on News

RELAXO FOOTWEARS Announces Quarterly Results (2QFY21); Net Profit Up 6.5% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, RELAXO FOOTWEARS has posted a net profit of Rs 751 m (up 6.5% YoY). Sales on the other hand came in at Rs 6 bn (down 7.4% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

RELAXO FOOTWEARS Announces Quarterly Results (1QFY21); Net Profit Down 51.3% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, RELAXO FOOTWEARS has posted a net profit of Rs 242 m (down 51.3% YoY). Sales on the other hand came in at Rs 4 bn (down 43.9% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

RELAXO FOOTWEARS Announces Quarterly Results (4QFY20); Net Profit Down 4.8% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, RELAXO FOOTWEARS has posted a net profit of Rs 518 m (down 4.8% YoY). Sales on the other hand came in at Rs 5 bn (down 15.0% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

RELAXO FOOTWEARS Announces Quarterly Results (3QFY20); Net Profit Up 52.0% (Quarterly Result Update)

Feb 3, 2020 | Updated on Feb 3, 2020

For the quarter ended December 2019, RELAXO FOOTWEARS has posted a net profit of Rs 542 m (up 52.0% YoY). Sales on the other hand came in at Rs 6 bn (up 8.8% YoY). Read on for a complete analysis of RELAXO FOOTWEARS's quarterly results.

RELAXO FOOTWEARS 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of RELAXO FOOTWEARS for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of RELAXO FOOTWEARS. Also includes updates on the valuation of RELAXO FOOTWEARS.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - COLGATE COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS